Comparison

Lenalidomide (hemihydrate) European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Clone N/A
Amount 100 mg
Item no. HY-A0003B-100mg
Targets Ligands for E3 Ligase; Molecular Glues; Apoptosis
CASRN 847871-99-2
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
Lenalidomide hemihydrate (CC-5013 hemihydrate), a derivative of Thalidomide, acts as molecular glue. Lenalidomide hemihydrate is an orally active immunomodulator. Lenalidomide hemihydrate (CC-5013 hemihydrate) is a ligand of ubiquitin E3 ligase cereblon (CRBN), and it causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. Lenalidomide hemihydrate (CC-5013 hemihydrate) specifically inhibits growth of mature B-cell lymphomas, including multiple myeloma, and induces IL-2 release from T cells[1][2].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
268.27
Clinical_Information
Launched
Manufacturers Research_Area
Cancer
Solubility
DMSO : 50 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL
Manufacturers Target
Apoptosis; Ligands for E3 Ligase; Molecular Glues
Isoform
Cereblon
Pathway
Apoptosis; PROTAC
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close